UK tribunal denies excessive-pricing appeals

The UK’s Competition Appeal Tribunal has denied separate requests from the Competition and Markets Authority, Pfizer and Flynn Pharma to appeal against aspects of its phenytoin excessive-pricing decision last month, and ordered an immediate remittal of the case to the authority.


Get unlimited access to all Global Competition Review content